Medivolve Inc.
Medivolve Inc. MEDVF Peers
See (MEDVF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MEDVF | $0.00 | N/A | 54K | -0.03 | -$0.07 | N/A |
| LZAGY | $68.44 | +0.25% | 49.4B | 63.37 | $1.08 | +0.75% |
| LZAGF | $693.60 | +1.70% | 48.8B | 64.10 | $10.82 | +0.42% |
| WUXAY | $8.37 | +0.97% | 25.1B | 15.50 | $0.54 | +0.78% |
| WUXIF | $7.34 | N/A | 20.7B | 13.59 | $0.54 | +0.52% |
| BMXMF | $129.73 | +0.00% | 15.3B | 31.41 | $4.13 | +0.71% |
| ERFSF | $64.59 | -0.51% | 11.4B | 27.25 | $2.37 | +1.65% |
| SKHCF | $17.76 | -1.88% | 8.5B | 24.33 | $0.73 | +3.95% |
| SKHHY | $17.00 | +0.06% | 8.2B | 23.29 | $0.73 | +3.97% |
| DSRLF | $104.69 | +0.00% | 5.6B | 26.57 | $3.94 | +1.30% |
Stock Comparison
MEDVF vs LZAGY Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, LZAGY has a market cap of 49.4B. Regarding current trading prices, MEDVF is priced at $0.00, while LZAGY trades at $68.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas LZAGY's P/E ratio is 63.37. In terms of profitability, MEDVF's ROE is +0.57%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, MEDVF is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs LZAGF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, LZAGF has a market cap of 48.8B. Regarding current trading prices, MEDVF is priced at $0.00, while LZAGF trades at $693.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas LZAGF's P/E ratio is 64.10. In terms of profitability, MEDVF's ROE is +0.57%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, MEDVF is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs WUXAY Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, WUXAY has a market cap of 25.1B. Regarding current trading prices, MEDVF is priced at $0.00, while WUXAY trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas WUXAY's P/E ratio is 15.50. In terms of profitability, MEDVF's ROE is +0.57%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, MEDVF is less volatile compared to WUXAY. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs WUXIF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, WUXIF has a market cap of 20.7B. Regarding current trading prices, MEDVF is priced at $0.00, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, MEDVF's ROE is +0.57%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, MEDVF and WUXIF have similar daily volatility (0.00).
MEDVF vs BMXMF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, BMXMF has a market cap of 15.3B. Regarding current trading prices, MEDVF is priced at $0.00, while BMXMF trades at $129.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas BMXMF's P/E ratio is 31.41. In terms of profitability, MEDVF's ROE is +0.57%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, MEDVF is less volatile compared to BMXMF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs ERFSF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, ERFSF has a market cap of 11.4B. Regarding current trading prices, MEDVF is priced at $0.00, while ERFSF trades at $64.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas ERFSF's P/E ratio is 27.25. In terms of profitability, MEDVF's ROE is +0.57%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, MEDVF is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs SKHCF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, SKHCF has a market cap of 8.5B. Regarding current trading prices, MEDVF is priced at $0.00, while SKHCF trades at $17.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas SKHCF's P/E ratio is 24.33. In terms of profitability, MEDVF's ROE is +0.57%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, MEDVF is less volatile compared to SKHCF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs SKHHY Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, SKHHY has a market cap of 8.2B. Regarding current trading prices, MEDVF is priced at $0.00, while SKHHY trades at $17.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas SKHHY's P/E ratio is 23.29. In terms of profitability, MEDVF's ROE is +0.57%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, MEDVF is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs DSRLF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, DSRLF has a market cap of 5.6B. Regarding current trading prices, MEDVF is priced at $0.00, while DSRLF trades at $104.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas DSRLF's P/E ratio is 26.57. In terms of profitability, MEDVF's ROE is +0.57%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, MEDVF is less volatile compared to DSRLF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs HNGZY Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, HNGZY has a market cap of 4.5B. Regarding current trading prices, MEDVF is priced at $0.00, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, MEDVF's ROE is +0.57%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, MEDVF is less volatile compared to HNGZY. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs VIMGF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, VIMGF has a market cap of 1.8B. Regarding current trading prices, MEDVF is priced at $0.00, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, MEDVF's ROE is +0.57%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, MEDVF and VIMGF have similar daily volatility (0.00).
MEDVF vs MRCHF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, MEDVF is priced at $0.00, while MRCHF trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas MRCHF's P/E ratio is 62.35. In terms of profitability, MEDVF's ROE is +0.57%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, MEDVF is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs IDGXF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, IDGXF has a market cap of 186M. Regarding current trading prices, MEDVF is priced at $0.00, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, MEDVF's ROE is +0.57%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, MEDVF is less volatile compared to IDGXF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs EDTXF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, EDTXF has a market cap of 179.6M. Regarding current trading prices, MEDVF is priced at $0.00, while EDTXF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas EDTXF's P/E ratio is -10.50. In terms of profitability, MEDVF's ROE is +0.57%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, MEDVF is less volatile compared to EDTXF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs AMCY Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, MEDVF is priced at $0.00, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas AMCY's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to AMCY's ROE of N/A. Regarding short-term risk, MEDVF and AMCY have similar daily volatility (0.00).
MEDVF vs NNGRF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, MEDVF is priced at $0.00, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, MEDVF's ROE is +0.57%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, MEDVF and NNGRF have similar daily volatility (0.00).
MEDVF vs ATLN Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, ATLN has a market cap of 147.1M. Regarding current trading prices, MEDVF is priced at $0.00, while ATLN trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas ATLN's P/E ratio is -0.68. In terms of profitability, MEDVF's ROE is +0.57%, compared to ATLN's ROE of -19.68%. Regarding short-term risk, MEDVF is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs CORBF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, CORBF has a market cap of 133.9M. Regarding current trading prices, MEDVF is priced at $0.00, while CORBF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas CORBF's P/E ratio is 3.03. In terms of profitability, MEDVF's ROE is +0.57%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, MEDVF and CORBF have similar daily volatility (0.00).
MEDVF vs THOXF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, MEDVF is priced at $0.00, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas THOXF's P/E ratio is -14.40. In terms of profitability, MEDVF's ROE is +0.57%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, MEDVF is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs DIUXF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, MEDVF is priced at $0.00, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, MEDVF's ROE is +0.57%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, MEDVF and DIUXF have similar daily volatility (0.00).
MEDVF vs ANPCF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, ANPCF has a market cap of 100M. Regarding current trading prices, MEDVF is priced at $0.00, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, MEDVF's ROE is +0.57%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, MEDVF is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs TIHE Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, MEDVF is priced at $0.00, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas TIHE's P/E ratio is 0.32. In terms of profitability, MEDVF's ROE is +0.57%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, MEDVF and TIHE have similar daily volatility (0.00).
MEDVF vs BIOGF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, MEDVF is priced at $0.00, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, MEDVF's ROE is +0.57%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, MEDVF and BIOGF have similar daily volatility (0.00).
MEDVF vs PCNEF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, MEDVF is priced at $0.00, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, MEDVF's ROE is +0.57%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, MEDVF and PCNEF have similar daily volatility (0.00).
MEDVF vs PFGTF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, PFGTF has a market cap of 50.6M. Regarding current trading prices, MEDVF is priced at $0.00, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas PFGTF's P/E ratio is -3.11. In terms of profitability, MEDVF's ROE is +0.57%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, MEDVF is less volatile compared to PFGTF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs CLIFF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, MEDVF is priced at $0.00, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, MEDVF's ROE is +0.57%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, MEDVF is less volatile compared to CLIFF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs BIOQ Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, BIOQ has a market cap of 40.2M. Regarding current trading prices, MEDVF is priced at $0.00, while BIOQ trades at $45.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas BIOQ's P/E ratio is 15.85. In terms of profitability, MEDVF's ROE is +0.57%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, MEDVF is less volatile compared to BIOQ. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs ANPCY Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, ANPCY has a market cap of 35.5M. Regarding current trading prices, MEDVF is priced at $0.00, while ANPCY trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas ANPCY's P/E ratio is -1.20. In terms of profitability, MEDVF's ROE is +0.57%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, MEDVF and ANPCY have similar daily volatility (0.00).
MEDVF vs SNANF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, SNANF has a market cap of 29M. Regarding current trading prices, MEDVF is priced at $0.00, while SNANF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas SNANF's P/E ratio is -13.40. In terms of profitability, MEDVF's ROE is +0.57%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, MEDVF is less volatile compared to SNANF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs IMMVF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, MEDVF is priced at $0.00, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, MEDVF's ROE is +0.57%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, MEDVF is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs PCHM Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, PCHM has a market cap of 21.7M. Regarding current trading prices, MEDVF is priced at $0.00, while PCHM trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas PCHM's P/E ratio is -0.02. In terms of profitability, MEDVF's ROE is +0.57%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, MEDVF is less volatile compared to PCHM. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs VILGF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, MEDVF is priced at $0.00, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas VILGF's P/E ratio is -0.30. In terms of profitability, MEDVF's ROE is +0.57%, compared to VILGF's ROE of N/A. Regarding short-term risk, MEDVF and VILGF have similar daily volatility (0.00).
MEDVF vs BMKDF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, BMKDF has a market cap of 19.7M. Regarding current trading prices, MEDVF is priced at $0.00, while BMKDF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas BMKDF's P/E ratio is -21.72. In terms of profitability, MEDVF's ROE is +0.57%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, MEDVF is less volatile compared to BMKDF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs PMSNF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, PMSNF has a market cap of 14.8M. Regarding current trading prices, MEDVF is priced at $0.00, while PMSNF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas PMSNF's P/E ratio is -2.50. In terms of profitability, MEDVF's ROE is +0.57%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, MEDVF and PMSNF have similar daily volatility (0.00).
MEDVF vs IZOZF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, IZOZF has a market cap of 13.7M. Regarding current trading prices, MEDVF is priced at $0.00, while IZOZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas IZOZF's P/E ratio is -7.57. In terms of profitability, MEDVF's ROE is +0.57%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, MEDVF is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs ABDXF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, MEDVF is priced at $0.00, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, MEDVF's ROE is +0.57%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, MEDVF and ABDXF have similar daily volatility (0.00).
MEDVF vs MXDHF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, MEDVF is priced at $0.00, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, MEDVF's ROE is +0.57%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, MEDVF and MXDHF have similar daily volatility (0.00).
MEDVF vs LDXHF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, LDXHF has a market cap of 7.5M. Regarding current trading prices, MEDVF is priced at $0.00, while LDXHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas LDXHF's P/E ratio is -1.00. In terms of profitability, MEDVF's ROE is +0.57%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, MEDVF is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs VRCDF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, MEDVF is priced at $0.00, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, MEDVF's ROE is +0.57%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, MEDVF is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs TDSGF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, TDSGF has a market cap of 7M. Regarding current trading prices, MEDVF is priced at $0.00, while TDSGF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas TDSGF's P/E ratio is -2.33. In terms of profitability, MEDVF's ROE is +0.57%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, MEDVF and TDSGF have similar daily volatility (0.00).
MEDVF vs SQIDF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, MEDVF is priced at $0.00, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, MEDVF's ROE is +0.57%, compared to SQIDF's ROE of +0.00%. Regarding short-term risk, MEDVF is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs SLDX Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, SLDX has a market cap of 4.8M. Regarding current trading prices, MEDVF is priced at $0.00, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas SLDX's P/E ratio is -0.01. In terms of profitability, MEDVF's ROE is +0.57%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, MEDVF is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs JMPHF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, JMPHF has a market cap of 4.2M. Regarding current trading prices, MEDVF is priced at $0.00, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, MEDVF's ROE is +0.57%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, MEDVF is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs GNTLF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, MEDVF is priced at $0.00, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, MEDVF's ROE is +0.57%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, MEDVF and GNTLF have similar daily volatility (0.00).
MEDVF vs SZLSF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, SZLSF has a market cap of 3.6M. Regarding current trading prices, MEDVF is priced at $0.00, while SZLSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas SZLSF's P/E ratio is -0.02. In terms of profitability, MEDVF's ROE is +0.57%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, MEDVF is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs IDXG Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, IDXG has a market cap of 3.5M. Regarding current trading prices, MEDVF is priced at $0.00, while IDXG trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas IDXG's P/E ratio is 2.79. In terms of profitability, MEDVF's ROE is +0.57%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, MEDVF is less volatile compared to IDXG. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs AVCRF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, AVCRF has a market cap of 3.3M. Regarding current trading prices, MEDVF is priced at $0.00, while AVCRF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas AVCRF's P/E ratio is -3.22. In terms of profitability, MEDVF's ROE is +0.57%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, MEDVF is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs ICBU Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, ICBU has a market cap of 2.9M. Regarding current trading prices, MEDVF is priced at $0.00, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas ICBU's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, MEDVF is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs IDTA Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, IDTA has a market cap of 2.3M. Regarding current trading prices, MEDVF is priced at $0.00, while IDTA trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas IDTA's P/E ratio is 5.60. In terms of profitability, MEDVF's ROE is +0.57%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, MEDVF and IDTA have similar daily volatility (0.00).
MEDVF vs IBXXF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, IBXXF has a market cap of 1.6M. Regarding current trading prices, MEDVF is priced at $0.00, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, MEDVF's ROE is +0.57%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, MEDVF is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs IVRO Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, IVRO has a market cap of 1.4M. Regarding current trading prices, MEDVF is priced at $0.00, while IVRO trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas IVRO's P/E ratio is -0.78. In terms of profitability, MEDVF's ROE is +0.57%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, MEDVF is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs DIGP Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, MEDVF is priced at $0.00, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas DIGP's P/E ratio is -1.04. In terms of profitability, MEDVF's ROE is +0.57%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, MEDVF is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs NSTM Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, NSTM has a market cap of 937.6K. Regarding current trading prices, MEDVF is priced at $0.00, while NSTM trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas NSTM's P/E ratio is -0.33. In terms of profitability, MEDVF's ROE is +0.57%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, MEDVF is less volatile compared to NSTM. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs SCRSF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, SCRSF has a market cap of 861.7K. Regarding current trading prices, MEDVF is priced at $0.00, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, MEDVF's ROE is +0.57%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, MEDVF and SCRSF have similar daily volatility (0.00).
MEDVF vs EPGNF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, EPGNF has a market cap of 692.8K. Regarding current trading prices, MEDVF is priced at $0.00, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, MEDVF's ROE is +0.57%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, MEDVF is less volatile compared to EPGNF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs MBGNF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, MEDVF is priced at $0.00, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, MEDVF's ROE is +0.57%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, MEDVF and MBGNF have similar daily volatility (0.00).
MEDVF vs NVTAQ Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, MEDVF is priced at $0.00, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, MEDVF's ROE is +0.57%, compared to NVTAQ's ROE of +1.79%. Regarding short-term risk, MEDVF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs RSHN Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, RSHN has a market cap of 81.7K. Regarding current trading prices, MEDVF is priced at $0.00, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas RSHN's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, MEDVF is less volatile compared to RSHN. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs ARYC Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, MEDVF is priced at $0.00, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas ARYC's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, MEDVF is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs HCLC Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, MEDVF is priced at $0.00, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas HCLC's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, MEDVF and HCLC have similar daily volatility (0.00).
MEDVF vs RNVA Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, RNVA has a market cap of 43.1K. Regarding current trading prices, MEDVF is priced at $0.00, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas RNVA's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, MEDVF and RNVA have similar daily volatility (0.00).
MEDVF vs CHHL Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, MEDVF is priced at $0.00, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas CHHL's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, MEDVF is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs IHTI Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, MEDVF is priced at $0.00, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas IHTI's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, MEDVF is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs MEDD Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, MEDVF is priced at $0.00, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas MEDD's P/E ratio is -0.01. In terms of profitability, MEDVF's ROE is +0.57%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, MEDVF and MEDD have similar daily volatility (0.00).
MEDVF vs TOMDF Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, MEDVF is priced at $0.00, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas TOMDF's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, MEDVF is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs CGNH Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, MEDVF is priced at $0.00, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas CGNH's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, MEDVF and CGNH have similar daily volatility (0.00).
MEDVF vs ABMC Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, MEDVF is priced at $0.00, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas ABMC's P/E ratio is 0.01. In terms of profitability, MEDVF's ROE is +0.57%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, MEDVF and ABMC have similar daily volatility (0.00).
MEDVF vs RGDXQ Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, MEDVF is priced at $0.00, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, MEDVF is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs DMTKQ Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, MEDVF is priced at $0.00, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, MEDVF is less volatile compared to DMTKQ. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs GWHP Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, MEDVF is priced at $0.00, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas GWHP's P/E ratio is -0.00. In terms of profitability, MEDVF's ROE is +0.57%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, MEDVF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs CYPS Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, CYPS has a market cap of 811. Regarding current trading prices, MEDVF is priced at $0.00, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas CYPS's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to CYPS's ROE of N/A. Regarding short-term risk, MEDVF is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for MEDVF.
MEDVF vs ROSGQ Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, MEDVF is priced at $0.00, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, MEDVF and ROSGQ have similar daily volatility (0.00).
MEDVF vs BIOCQ Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, MEDVF is priced at $0.00, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, MEDVF's ROE is +0.57%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, MEDVF and BIOCQ have similar daily volatility (0.00).
MEDVF vs HTGMQ Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, MEDVF is priced at $0.00, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, MEDVF and HTGMQ have similar daily volatility (0.00).
MEDVF vs OPGX Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, OPGX has a market cap of 17. Regarding current trading prices, MEDVF is priced at $0.00, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas OPGX's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, MEDVF and OPGX have similar daily volatility (0.00).
MEDVF vs AGHC Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, AGHC has a market cap of 0. Regarding current trading prices, MEDVF is priced at $0.00, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas AGHC's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, MEDVF and AGHC have similar daily volatility (0.00).
MEDVF vs EPGNY Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, MEDVF is priced at $0.00, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, MEDVF's ROE is +0.57%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, MEDVF and EPGNY have similar daily volatility (0.00).
MEDVF vs MRPS Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, MRPS has a market cap of 0. Regarding current trading prices, MEDVF is priced at $0.00, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas MRPS's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to MRPS's ROE of N/A. Regarding short-term risk, MEDVF and MRPS have similar daily volatility (0.00).
MEDVF vs BGNX Comparison
MEDVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDVF stands at 54K. In comparison, BGNX has a market cap of 0. Regarding current trading prices, MEDVF is priced at $0.00, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDVF currently has a P/E ratio of -0.03, whereas BGNX's P/E ratio is N/A. In terms of profitability, MEDVF's ROE is +0.57%, compared to BGNX's ROE of N/A. Regarding short-term risk, MEDVF and BGNX have similar daily volatility (0.00).